欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
本帖最后由 一沙一叶 于 2015-2-13 08:45 编辑
欧盟GMP附录1无菌生产指南修订版概念稿
At the beginning of February 2015, the European Medicines Agency(EMA) published a Concept Paper on the revision of Annex 1. Annex 1 of the EU GMP Guide is theGuideline for Europe which describes the requirements on the manufacture ofsterile dosage forms. The reasonsgiven for the revision are technological developments as well as the adaptationto the ICH Q9 and Q10 guidelines. Thelast, relatively extensive revision of Annex 1 dates back to 2007. The new version of Annex 1 should alsoinclude new technologies in sterile production - not previously covered -beside the adaptation mentioned. 2015年二月初,EMA颁布了附录1修订版的概念稿。附录1是描述无菌制剂的生产要求的指导原则。修订的理由是由于技术发展和ICH Q9和Q10指南的应用。附录1的上一个版本可追溯到2007年。新的版本将包括无菌生产的新技术—以前未涉及的—包括刚提及的应用。 The paper contains a veryinteresting paragraph which describes the necessity of a change if there is arevision of a pharmacopoeia monograph. Here, the method for the production of WFI (water for injection)without distillation is mentioned. Thisis all the more interesting as there is currently no information from the EDQM- the editor of the European Pharmacopoeia - that a change to this method isplanned soon. So far, distillation only is allowed for the production of WFI accordingto the European Pharmacopoeia. 这份概念稿包含一个很有意思的章节,这章描述了当药典专论修订时变更的必要性。它还提及了不采用蒸馏法的注射用水的生产方法。这个是更吸引人的,因为EDQM(英国药典编著者)目前尚无这方面的信息,不就将计划这个方法的变更。目前,蒸馏法是欧洲药典允许的WFI生产的唯一方法。
附件非全文稿,有全文的人欢迎共享
|